PI3K: A rational target for ovarian cancer therapy?

Paul Dent, Steven Grant, Paul B. Fisher, David T. Curiel

Research output: Contribution to journalComment/debate

7 Scopus citations
Original languageEnglish
Pages (from-to)27-30
Number of pages4
JournalCancer Biology and Therapy
Volume8
Issue number1
DOIs
StatePublished - Jan 2009

Keywords

  • Cisplatin
  • Mutation
  • Ovarian
  • PI3K
  • Taxane
  • Taxol
  • Therapy

Cite this